"10.1371_journal.pone.0139370","plos one","2015-10-01T00:00:00Z","Jana Knop; Shingen Misaka; Katrin Singer; Eva Hoier; Fabian Müller; Hartmut Glaeser; Jörg König; Martin F Fromm","Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Department of Pharmacology, School of Medicine, Fukushima Medical University, Fukushima, Japan","Conceived and designed the experiments: J. Knop SM FM HG J. König MFF. Performed the experiments: J. Knop SM KS EH HG. Analyzed the data: J. Knop SM FM HG J. König MFF. Contributed reagents/materials/analysis tools: J. König MFF. Wrote the paper: J. Knop SM FM HG J. König MFF.","F.M. holds a minor share of stock in Novartis, received research funding from Sanofi-Aventis Deutschland and is now an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. M.F.F. reported receiving personal compensation for expert testimony from Boehringer Ingelheim Pharma and payments for lectures from Bayer-Schering Pharma, Boehringer Ingelheim Pharma, Sanofi-Aventis Deutschland and Merck KGaA. M.F.F.’s institution received compensation for commissioned research of his group from Merck KGaA and Sanofi-Aventis Deutschland and for supply for in vitro studies from Gilead. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The remaining authors declare no conflicts of interest.","2015","10","Jana Knop","JK",8,TRUE,1,1,1,1,TRUE,TRUE,TRUE,6,"2;3;4;5;6;8",TRUE
